FRANK H-G, MALEKZADEH F, KERTSCHANSKA S, CRESCIMANNO C, CASTELLUCCI M, LANG, I et al. (1994)
Immunohistochemistry of two different types of placental
fibrinoid. Acta Anatomica 150, 55–68.
GOW L, CAMPBELL DM, OGSTON D (1984) The fibrinolytic
system in pre-eclampsia. Journal of Clinical Pathology 37, 56–58.
HAMILTON WJ, BOYD JD (1960) Development of the human
placenta in the first three months of gestation. Journal of
Anatomy 94, 297–328.
HOFMANN GE, GLATSTEIN I, SCHATZ F, HELLER D,
DELIGDISCH L (1994) Immunohistochemical localization of
urokinase-type plasminogen activator and plasminogen activator
inhibitor 1 and 2 in early human implantation sites. American
Journal Obstetrics and Gynecology 170, 671–676.
JONASSON A, LARSSON B, LECANDER I, A/ STEDT B (1989)
Placental and decidual u-PA, t-PA, PAI-1 and PAI-2 concentrations, as affected by cervical dilatation with laminaria tents or
Hegar dilators. Thrombosis Research 53, 91–97.
JORGENSEN M, PHILIPS M, THORSEN S, SELMER J,
ZEUTHEN J (1987) Plasminogen activator inhibitor-1 is the
primary inhibitor of tissue-type plasminogen activator in pregnancy plasma. Thrombosis and Haemostasis 58, 872–878.
KAWANO T, MORIMOTO K, UEMURA Y (1968) Urokinase
inhibitor in human placenta. Nature, 217, 253–254.
KRUITHOF EK, TRAN-THANG C, GUDINCHET A,
HAUERT J, NICOLOSO G, GENTON C et al. (1987)
Fibrinolysis in pregnancy : a study of plasminogen activator
inhibitors. Blood 69, 460–466.
LECANDER I, A/ STEDT B (1987) Specific plasminogen activator
inhibitor of placental type PAI-2 occurring in amniotic fluid and
cord blood. Journal of Laboratory and Clinical Medicine 110,
602–605.
LIBRACH CL, WERB Z, FITZGERALD ML, KING CHIU,
CORWIN NM, ESTEVES RA et al. (1991) 92-kD type IV
collagenase mediates invasion of human cytotrophoblasts.
Journal of Cell Biology 113, 437–449.
LIOTTA LA, GOLDFARB RH, BRUNDAGE R, SIEGAL GP,
TERRANOVA V, GARBISA S (1981) Effect of plasminogen
activators (urokinase), plasmin and thrombin on glycoprotein
and collagenous components of the basement membrane. Cancer
Research 41, 4629–4636.
LIU YX, HU ZY, ZOU RJ, OCKLEFORD CD (1997)
Identification of secretion sites of tissue plasminogen activator
and plasminogen activator inhibitor type-1 in basal plates of
human and rhesus monkey placentae. Chinese Science Bulletin 42
1030–1033.
LIU YX, HU ZY, BYRNE S, ZOU RJ, NY T, D'LACEY C et al.
(1998) Localisation and distribution of tissue type and urokinase
type plasminogen activators and inhibitors Type 1 and Type 2 in
human and rhesus monkey fetal membranes. Placenta 19,
171–180.
LOSKUTOFF DJ (1991) Regulation of PAI-1 gene expression.
Fibrinolysis 5, 197–206.
MACKAY AR, CORBITT RH, HARTZLER JL, THORGEIRSSON, UP (1990) Basement membrane type IV collagen
degradation : evidence for the involvement of a proteolytic
cascade independent of metalloproteinases. Cancer Research 50,
5997–6001.
MARTIN O, ARIAS F (1982) Plasminogen activator production
by trophoblast cells in vitro : effect of steroid hormones and
protein synthesis inhibitors. American Journal of Obstetrics and
Gynecology 142, 402–409.
MEEKINS JW, PIJNENBORG R, HANSSENS M,
MCFADYEN IR, VAN ASSCHE A (1994) A study of placental
bed spiral arterioles and trophoblast invasion in normal and
severe pre-eclampsia pregnancies. British Journal of Obstetrics
and Gynecology 101, 669–674.
